Candel Therapeutics (CADL) Profit After Tax (2020 - 2023)
Historic Profit After Tax for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to -$11.1 million.
- Candel Therapeutics' Profit After Tax fell 11801.93% to -$11.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year decrease of 10155.1%. This contributed to the annual value of -$55.2 million for FY2024, which is 4549.67% down from last year.
- Per Candel Therapeutics' latest filing, its Profit After Tax stood at -$11.1 million for Q4 2023, which was down 11801.93% from -$8.4 million recorded in Q3 2023.
- Candel Therapeutics' Profit After Tax's 5-year high stood at $1.6 million during Q4 2021, with a 5-year trough of -$17.1 million in Q2 2021.
- For the 4-year period, Candel Therapeutics' Profit After Tax averaged around -$7.3 million, with its median value being -$8.4 million (2023).
- As far as peak fluctuations go, Candel Therapeutics' Profit After Tax surged by 11523.19% in 2021, and later tumbled by 87777.78% in 2023.
- Quarter analysis of 4 years shows Candel Therapeutics' Profit After Tax stood at -$10.5 million in 2020, then soared by 115.23% to $1.6 million in 2021, then tumbled by 418.86% to -$5.1 million in 2022, then tumbled by 118.02% to -$11.1 million in 2023.
- Its last three reported values are -$11.1 million in Q4 2023, -$8.4 million for Q3 2023, and -$9.6 million during Q2 2023.